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Vaccines, arguably the single most important intervention in improving human health, have
exploited the phenomenon of immunological memory. The elicitation of memory T cells
is often an essential part of successful long-lived protective immunity. Our understanding
of T cell memory has been greatly aided by the development of TCR Tg mice and MHC
tetrameric staining reagents that have allowed the precise tracking of antigen-speciﬁc
T cell responses. Indeed, following acute infection or immunization, naïveT cells undergo a
massive expansion culminating in the generation of a robust effector T cell population.
This peak effector response is relatively short-lived and, while most effector T cells die by
apoptosis, some remain and develop into memory cells. Although the molecular mecha-
nisms underlying this cell fate decision remain incompletely deﬁned, substantial progress
has been made, particularly with regards to CD8+ T cells. For example, the effector CD8+
T cells generated during a response are heterogeneous, consisting of cells with more
or less potential to develop into full-ﬂedged memory cells. Development of CD8+ T cell
memory is regulated by the transcriptional programs that control the differentiation and
survival of effectorT cells.While the type of antigenic stimulation and level of inﬂammation
control effector CD8+ T cell differentiation, availability of cytokines and their ability to
control expression and function of Bcl-2 family members governs their survival. These
distinct differentiation and survival programs may allow for ﬁner therapeutic intervention
to control both the quality and quantity of CD8+ T cell memory. Effector to memory
transition of CD4+ T cells is less well characterized than CD8+ T cells, emerging details
will be discussed.This review will focus on the recent progress made in our understanding
of the mechanisms underlying the development of T cell memory with an emphasis on
factors controlling survival of effector T cells.
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IMMUNOLOGICAL MEMORY
The concept of immunological memory has dated back to as
early as the ﬁfth century B.C. as the Athenian author Thucydides
mentioned in his scripts that people who survived plague would
not be attacked a second time (Thucydides and Marchant, 1899).
In seventh century, people drank snake venoms to get toxoid-
like immunity (Plotkin et al., 2008). In ancient China, people
blew powdered scabs of smallpox pustules into their nose to be
protected from smallpox, a process called variolation (Plotkin
et al., 2008). The process of variolation transferred to westward
to the Middle East along shipping routes when Lady Mary Wort-
ley Montagu witnessed this process and popularized variolation
in England in the 1700s. By the time Edward Jenner immunized a
child with cowpox and challenged him with smallpox, the concept
of immune “memory” or “immunity” existed. Nearly 100 years
elapsed before purposeful development of vaccines was attempted
against cholera toxin and the rabies virus by Pasteur (Plotkin et al.,
2008). Thus, the concept that prior exposure to a disease-causing
microorganism (or a close relative) could provide long-lasted pro-
tection against subsequent infection has been around for a very
long time. The subsequent large-scale development of effective
vaccines against yellow fever, smallpox, rabies, inﬂuenza, polio,
measles, mumps, diphtheria, Bordetella, hepatitis B, and, more
recently, rotavirus have saved countless lives and are one of the
greatest improvements to human health. Over the last few decades
with the advent of cellular and molecular approaches we are
started to unravel the mechanisms underlying immunological
memory.
Immunological memory has been deﬁned simply as the height-
ened immune response against a previously encountered pathogen
that is due to the increased numbers of antigen-speciﬁc cells
and their increased capacity to respond to secondary stimulation
(Murphy et al., 2011). Both arms of adaptive immunity; antibody
responses and T cell responses are quantitatively and qualita-
tively better than the primary responses. Immunological memory
has been utilized successfully for generating protective immunity
against many pathogens (Rappuoli, 2007). While it is clear that
B cell production of antibody is critical for the protective fea-
tures of many vaccines; long-lived T cell immunity is also critical
component induced by vaccines. This review will focus on recent
advances made in our understanding of mechanisms underlying
the development of memory T cell responses.
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TRACKING T CELL RESPONSES
One of the substantial developments in T cell biology over the
past few decades has been the ability to monitor T cells responses
at the single-cell level. Early work examining T cell function was
restricted to population based assays such as proliferation (3H
incorporation) for CD4+ T cells and CTL assays (51Cr release) for
CD8+ T cells. The development of TCR Tg mice and adoptive
transfer approaches for the ﬁrst time allowed tracking antigen-
speciﬁc (albeit monoclonal) T cell responses to nominal antigens
like ovalbumin (Kearney et al., 1994), to autoantigens (Katz et al.,
1993), or to viral antigens (Pircher et al., 1990). It was not until
the development of intracellular cytokine analysis by ﬂow cytome-
try, that endogenous, polyclonal, antigen-speciﬁc T cell responses
could be tracked at the single-cell level (Jung et al., 1993). While
this was a critical development, it also required a brief stimula-
tion of T cells either in vitro (Jung et al., 1993) or in vivo (Liu and
Whitton, 2005), which could change the gene expression and phe-
notype of the cells. In addition, it only allowed for examination of
cells whose cytokines are being measured, not necessarily all of the
T cells responding to the antigen/infection. In contrast, the devel-
opment of MHC tetramers was an absolutely critical tool for the
tracking and analysis of endogenous T cell responses without the
need for secondary stimulation (Altman et al., 1996). The devel-
opment of these tools for tracking endogenous T cell responses
has taught us a lot about T cell expansion, differentiation, and
localization.
KINETICS OF T CELL RESPONSES
The initial reports tracking endogenous T cell responses charac-
terized a massive expansion phase, in which responding T cells
undergo 15–20 rounds of division, a “contraction” phase in which
80–90% of the responding T cells undergo apoptosis, and a“main-
tenance” phase in which the remaining effector cells persist as
memory T cells and are maintained for the life of the animal
(Butz and Bevan, 1998; Murali-Krishna et al., 1998; Williams and
Bevan, 2007). For acute infections, the decline of T cell responses
occurs just after the infection is cleared (Figure 1). Further, the
expansion and contractionof CD8+ Tcell responses are of a signif-
icantly greater magnitude compared with CD4+ T cell responses
(Figure 1). While CD8+ T cell memory appears relatively sta-
ble over time, the CD4+ memory T cell population undergoes
a gradual attrition (Figure 1). Nonetheless, a central question
regarding the development of T cell memory is how some T
cells avoid death and develop into memory T cells. Over the
last decade, signiﬁcant progress has been made regarding our
understanding of themolecularmechanisms that contribute to the
death of most effector T cells and to the transcriptional network
that controls development of cells that are destined to become
memory T cells. Herein, we will describe the current under-
standing of how T cells transit from potent effectors to lifelong
protectors.
HETEROGENEITY OF EFFECTOR T CELLS
Effector CD8+ T cells are a heterogeneous population as deﬁned
by differential expression of surface markers. As only a small
fraction of effector T cells develop into memory cells, there has
been a quest to identify memory precursors early after infection.
FIGURE 1 | Kinetics ofT cell response after acute viral infection. Graph
shows total numbers (y -axis) of antigen-speciﬁc CD8+ (blue) and CD4+
(red) T cells days (x -axis) after acute infection as modiﬁed from Hinds et al.
(2007). Kinetics of viral load (orange) is also displayed on the graph.
Initially, it was unclear if memory cells went through an effector
stage or whether they were a distinct lineage without effector
characteristics. By using IFN-γ reporter mice or granzyme B
promoters, it has been shown that memory CD8+ T cells were
derived from IFN-γ producing and granzyme expressing effector
cells, respectively (Harrington et al., 2008; Bannard et al., 2009).
Importantly, adoptive transfer of a single naïve TCR transgenic
T cell into congenic mice generated heterogeneous subsets of
effector and memory CD8+ T cells in response to L. monocy-
togenes (Stemberger et al., 2007). Although these studies showed
that memory cells are derived from effector cells, not every effec-
tor cell maintains the same potential to become memory cell
over the course of infection. Many markers including cytokine
receptors, chemokine receptors, and stimulatory/inhibitory recep-
tors (described in more detail below) have been found to be
differentially expressed among effector cells at the peak of the
response (days 8–10 after infection). Among these markers, IL-
7Rα (CD127)which is down-regulated onmost of the effector cells
early after infection (Schluns et al., 2000), but the proportion of
cells expressing CD127 increases as the response contracts (Kaech
et al., 2003).
Further characterization of these effector CD8+ T cells has
revealed inverse expression of another marker, killer cell lectin-like
receptor subfamily G, member 1 (KLRG1) relative to expres-
sion of CD127 (Joshi et al., 2007). At the peak of the response,
two major CD8+ effector T cell populations emerge, one being
KLRG1hiCD127lo and another being KLRG1loCD127hi (Joshi
et al., 2007). Although the two subsets had similar cytotoxicity
and IFN-γ production, KLRG1loCD127hi cells had better produc-
tion of IL-2 (Sarkar et al., 2008). Adoptive transfer experiments
using TCR Tg cells have revealed that KLRG1hiCD127lo cells
slowly declined over time after transfer while KLRG1loCD127hi
cells were maintained at a greater level and persisted as long-lived
memory T cells (Joshi et al., 2007; Sarkar et al., 2008). Because of
these results, KLRG1hiCD127lo have been referred to as “short-
lived effector cells or SLECs” and KLRG1loCD127hi have been
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referred to as “memory precursor effector cells or MPECs” (Joshi
et al., 2007). While these markers have been helpful in identifying
certain populations of cells that have enrichments of cells with
more or less potential to develop into memory, further work
is necessary to more precisely deﬁne cells with memory poten-
tial. For example, while many SLECs die during contraction of
the response, not all do, and after contraction of the response is
largely complete, roughly half of the CD8+ T cells have an SLEC
phenotype (Joshi et al., 2007; Kaech and Wherry, 2007). Like-
wise, when assessing the numbers temporally, roughly 30–40% of
MPECs die during contraction of the response (Sarkar et al., 2008;
Kurtulus et al., 2011).
Other markers in addition to KLRG1 and CD127 are also used
to determine thememory potential of effector T cells. For instance,
CD127hi cells also express high levels of CD27, which is a mem-
ber of tumor necrosis factor receptor (TNF-R) family and the
chemokine receptor, CXCR3, but these cells are found to have low
expression of CD43 after infection with the Sendai virus (Kaech
et al., 2003; Hikono et al., 2007). Thus, while these markers have
helped identify cells with more or less ability to form long-lived
memory cells, further work is necessary to more precisely deﬁne
the cells within these subsets.
As primary infections have been difﬁcult to assess in humans,
it is unclear whether or not these precise effector subsets exist
amongst human T cells. However, recent studies have shed light
on effector cells in humans after vaccination with yellow fever
virus and the smallpox vaccine (Miller et al., 2008; Akondy et al.,
2009). Using MHC–peptide tetramers, the authors characterized
the antigen-speciﬁc T cell response across the effector response
and into memory from the peripheral blood. The phenotype of
activated CD8+ T cells were characterized by high expression of
HLA-DR and CD38 along with high expression of the prolifera-
tion marker Ki-67 and low expression of anti-apoptotic protein
Bcl-2 and CD127 (Miller et al., 2008). As antigen-speciﬁc human
T cells progressed into memory, they upregulated expression of
CD127, CCR7, CD45RA, CD28, and Bcl-2 (Miller et al., 2008;
Akondy et al., 2009). These memory cells were poly-functional
and maintained after 2 years (Akondy et al., 2009). Although
KLRG1 expression was not assessed in these studies, they showed
that CD127 expression was similar in human and mouse T cells
after infection. Thus, these studies showed that human and
mouse effector CD8+ T cells share similar expression of several
markers.
A more recent study performed a comprehensive analysis of 17
cell surface markers and 9 functional qualities of human CD8+ T
cell subsets using single-cell spectrometric analysis (cytometry by
time-of-ﬂight or CyTOF; Newell et al., 2012). Functional qualities
including expression of six different cytokines and cytotoxic gran-
ule components granzyme B and perforin were examined together
with surfacemarkers includingCD62L,CD45RA,CD45RO,CD27,
CD43, and KLRG1. This study found that naïve cells (CD45RA+
CD27+ CD62L+ CCR7+), central memory CD8+ T cells (TCM;
CD45RA− CD27+ CD62L+ CCR7+), effector memory CD8+ T
cells (TEM; CD45RA− CD27− CD62L− CCR7−) cells and termi-
nal effector cells (CD45RA+ CD27− CD62L− CD28− KLRG1+
CD57+) represented quite distinct subsets as previously described
(Sallusto et al., 1999). However, this study also found a range
of cells with combinatorial diversity of phenotypic and func-
tional markers in between these subsets suggesting a continuum
of T cell phenotypes (Newell et al., 2012). Unfortunately, this
did not longitudinally assess the response to infection as samples
were obtained from chronically infected individuals. Thus, more
work is needed to temporally examine the effector T cell subsets
in humans during both acute and chronic infections in greater
detail.
GENERATION OF EFFECTOR CD8+ T CELL SUBSETS
Recent work from a few labs has examined the potential in vivo
plasticity of these subsets and has tracked their emergence from
their naïve precursors. Interestingly, at the earliest times after the
response when the cells can be reliably detected, a population
appears that is KLRG1loCD127lo, which have been termed “early
effector cells or EECs” (Obar et al., 2010). When EECs were adop-
tively transferred into timed-infected recipient mice, they were
able to generate both KLRG1loCD127hi and KLRG1hiCD127lo
cells; transferred KLRG1loCD127hi cells were able to give rise to
some EECs early after transfer but predominantly remained as
KLRG1loCD127hi; while transferred KLRG1hiCD127lo cells were
largely unable to generate KLRG1loCD127hi cells (Obar et al.,
2011). Thus, shortly after the response, naïveT cells lose expression
of CD127, some cells stably reacquire CD127 expression, while
others upregulate KLRG1 and largely fail to upregulate CD127
(Joshi et al., 2007; Sarkar et al., 2008). At a molecular level this
regulation of CD127 appears to be due to the competing effects
of Gﬁ-1 and GABP-α at the CD127 locus (Chandele et al., 2008).
However, the mechanism(s) that control expression of Gﬁ-1 and
GABP-α remain unclear.
As differential expression of KLRG1 and CD127 has allowed
some demarcation of cells with more or less memory potential,
much work has been focused on mechanisms underlying their
generation. For example, one critical question is whether CD127
or KLRG1 are involved in the fate of effector T cells or whether
they are simply markers. One initial idea was that expression of
CD127 allowed effector CD8+ T cells to compete for IL-7 and,
in doing so, was instructive for their survival and/or develop-
ment into memory cells. However, while exogenous IL-7 could
protect effector CD4+ and CD8+ T cells from contraction of the
response (Tripathi et al., 2007; Nanjappa et al., 2008), transgenic
expression of CD127 failed to prevent contraction of the response
(Hand et al., 2007; Haring et al., 2008). Similarly, neutralization
or inhibition of IL-7 after infection failed to substantially exacer-
bate contraction of the effector CD4+ or CD8+ T cell responses
(Klonowski et al., 2006; Tripathi et al., 2007, 2010). A recent study
has shown that KLRG1-deﬁcient mice have no defects in mem-
ory T cell development (Grundemann et al., 2010), demonstrating
that KLRG1 is not necessary for effector/memory T cell differ-
entiation. However, given that there are multiple KLRG family
members and the fact that KLRG1 possesses an immunoreceptor
tyrosine-based inhibition motif (ITIM)-domain, makes it possi-
ble that KLRG1 contributes redundantly with other KLRG family
members to limit signaling events within KLRG1hiCD127lo cells.
On the other hand, if neither KLRG1 nor CD127 are instructive,
what are the mechanisms that control generation of these two
subsets?
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INFLAMMATION DIRECTS EXPANSION OF KLRG1hiCD127lo
CELLS
Recent work has revealed an intriguing and complex interrelation-
ship between transcriptional programs that balance input from
surrounding inﬂammatory stimuli to promote a self-renewal pro-
gram that maintains lifelong immunity. The transcription factor
t-bet, initially described as amaster regulator of Th1 fate, favors the
generation of KLRG1hiCD127lo CD8+ T cells (Joshi et al., 2007).
Loss of tbx21 (gene encoding t-bet) reduced the formation of
KLRG1hiCD127lo effector CD8+ T cells, while graded increases in
t-bet expression, whether retrovirally overexpressed or induced by
varying amounts of inﬂammatory stimuli (e.g., TLR stimuli, IL-
12, etc.) gradually increased the generation of KLRG1hiCD127lo
CD8+ T cells (Badovinac and Harty, 2007; Joshi et al., 2007).
Importantly, the overall numbers of KLRG1loCD127hi CD8+ T
cells in these t-bet titration experiments did not change, sug-
gesting a critical role of t-bet in the formation of cells with a
KLRG1hiCD127lo phenotype, but not an MPEC phenotype.
Importantly, KLRG1hiCD127lo cells express more t-bet com-
pared to KLRG1lo CD127hi cells, and the reverse is true for
eomesodermin (eomes; Joshi et al., 2007, 2011). While neither
subset is truly negative for either molecule, both are required for
expression of CD122 and a lower t-bet:eomes ratio correlates with
KLRG1loCD127hi cells and long-lived memory (Intlekofer et al.,
2005, 2007; Banerjee et al., 2010). Thus, control of the t-bet:eomes
ratio, as dictated by the level of inﬂammation is likely critical in
controlling CD8+ T cell memory generation.
Understanding the regulation of this t-bet:eomes balance is the
focus of several recent papers, which have outlined a complex
interplay between t-bet and the mTORC1/AKT/FOXO signaling
network (Figure 2). Overexpression of a constitutively active (ca)
AKT transgene led to signiﬁcantly increased expression of t-bet
and a concomitant decrease in eomes expression (Kim et al., 2012).
Conversely, caFOXO overexpression decreases expression of t-bet
and increases expression of eomes (Rao et al., 2012). Inﬂamma-
tion, via IL-12 (and possibly other inﬂammatory mediators) has
been shown to increase mTORC1/AKT, which in turn decrease
FOXO activity and enhance t-bet expression (Rao et al., 2010,
2012). However, a complicating factor in many of these stud-
ies is that caAKT appears to also decrease expression of CD127
(Hand et al., 2010), likely through inactivation of FOXO1 (Kerdiles
et al., 2009), making it difﬁcult to clearly distinguish the effec-
tor CD8+ subsets. Thus, while the current data suggest that
mTORC1/AKT/FOXO signaling is differentially balanced between
the subsets, it is also formally possible that a proper balance of
mTORC1/AKT/FOXO signaling is necessary to emerge from the
FIGURE 2 | Pathways governing the survival and differentiation
of effector CD8+ T cells.The differentiation of early effector cells
(KLRG1loCD127lo) into KRLG1hiCD127lo or KLRG1loCD127hi cells is
regulated by inﬂammatory cytokines and by IL-10 and IL-21. IL-12 can activate
STAT4 and PI-3K signaling which modulates mTOR kinases and subsequent
Akt phosphorylation at s473. Phosphorylated Akt can phosphorylate and
inactivate FOXO proteins. This favors an increased t-bet:eomes ratio and
differentiation into KLRG1hiCD127lo cells. On the other hand, Stat3
phosphorylation by IL-10 and IL-21 increases eomes and other transcription
factors required for differentiation of KLRG1loCD127hi cells. SOCS3 induced
by Stat3 can, then, inhibit IL-12 signaling, effectively shielding KLRG1lo
CD127hi cells from inﬂammation. Interestingly, survival of effector subsets
are regulated by γc cytokines IL-15 and IL-7 via signals driven through STAT5
which appear largely independent of differentiation. While KLRG1hiCD127lo
cells can only receive IL-15 signals; IL-15 and IL-7 can both activate Stat5
signaling in KLRG1loCD127hi cells. This results in Bcl-2 upregulation and
inhibition of Bim-mediated apoptosis. IL-15 becomes limiting for KLRG1hi
CD127lo cells reducing their ability to sustain Bcl-2 levels in the face of
TGF-β signaling. Id2 may also control Bim levels in KLRG1hiCD127lo cells.
FOXO proteins may be at the intersection of survival and differentiation
pathways as it can regulate both Bim expression and inﬂuence the
t-bet:eomes ratio.
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EEC compartment. More work will be necessary to cleanly dissect
the factors that control mTORC1/AKT/FOXO signaling between
the effector subsets.
THE ROLE OF ANTIGEN PRESENTATION IN THE GENERATION
OF EFFECTOR AND MEMORY CD8+ T CELLS
Obviously, antigen initially drives the metamorphoses of naïve
to effector T cell. Previous studies showed that limiting antigen
exposure to the ﬁrst 24 h was sufﬁcient to drive expansion and dif-
ferentiation into full-ﬂedged effector (van Stipdonk et al., 2001)
and memory (Kaech and Ahmed, 2001) cells in vitro. However,
stimulation longer than 40 h in the presence of IL-12 resulted
in a substantial increase in CD8+ clonal expansion compared to
shorter stimulation, indicating the role of inﬂammatory cytokines
in the magnitude of the response (Curtsinger et al., 2003). These
studies suggested at least two interactions of T cells with antigen-
presenting cells (APCs) promoted optimal effector and memory
responses. Interestingly, limiting antigen display during Listeria
infection by antibiotic treatment 24 h after infection resulted in a
decreased magnitude of the response but a similar contraction
(Badovinac et al., 2002). Secondary challenge of the antibiotic
treated mice revealed an enhanced secondary response, despite
the decreased magnitude of the primary response (Badovinac
et al., 2002). Subsequently, it was found that antibiotic treatment
prior to infection in this same model resulted in signiﬁcantly
enhanced generation of cells with a memory phenotype (CD127hi;
Badovinac et al., 2004). However, in this study, it was shown that
antibiotic treatment signiﬁcantly decreased inﬂammation, and it
was this attribute, rather than effects on antigen display that likely
contributed to the increasedmemory cells (Badovinac et al., 2004).
Similarly, adoptive transfer of naïve TCR Tg cells into mice with an
ongoing immune response (as inﬂammation is waning), results in
accelerated development of memory cells (D’Souza and Hedrick,
2006; Sarkar et al., 2007). Furthermore, attempts to restrict antigen
display by elimination of dendritic cells (DCs) using CD11c-DTR
mice also resulted in a decreased magnitude of the CD8+ T cell
response, but accelerated development of cells with memory char-
acteristics (Prlic et al., 2006). However, as DCs are also the same
cells that secrete pro-inﬂammatory mediators, the degree to which
their role as antigen presenters versus producers of inﬂammation
is difﬁcult to separate. Thus, while it is likely that limiting anti-
gen display may contribute to memory cell development, further
work is necessary to cleanly separate inﬂammatory stimuli from
antigen-presentation.
MIGRATION AND LOCALIZATION OF EFFECTOR AND
MEMORY CD8+ T CELL SUBSETS
Being at the right place at the right time may also be important for
memory cell development. Indeed, recent work has shown that, in
the spleen KLRG1loCD127hi CD8+ T cells are mostly localized
to the T cell zones in the white pulp, while KLRG1hiCD127lo
CD8+ T cells are localized to the red pulp (Jung et al., 2010).
CXCR3 signals may also be critical in attracting KLRG1hiCD127lo
cells to the marginal zone areas, where they may be exposed to
more inﬂammatory stimuli (Kurachi et al., 2011). Also, T cells in
CXCR3/CCR5-deﬁcient mice had similar problems with localiza-
tion, actually failed to undergo contraction in the spleen, and
had an emergence of KLRG1loCD127hi cells (Kohlmeier et al.,
2011). In these studies, it was also clear that the absence of
CXCR3/CCR5 restricted the accumulation of effector T cells to
sites of infection/inﬂammation as plenty of cells were recruited to
the lung, but not to areas of viral replication within the infected
lung. While overall tissue localization may direct CD8+ T cells to
general areas of inﬂammation, the ﬁner tuning of their migra-
tion within these organs is likely mediated by signals through
CXCR3/CCR5. Intriguingly, CXCR3 signals through AKT/FOXO
transcription factors raising the intriguing possibility that, in addi-
tion to promoting appropriate localization, differentiation signals
driven by these chemokine receptors may also contribute to effec-
tor T cell heterogeneity. Conversely, high expression of CCR7 on
KLRG1loCD127hi cells likely fosters their migration to/retention
within the T cell zones where the ligands CCL19 and CCL21 are
highly expressed (Jung et al., 2010). This differential expression of
CCR7 may be part of the effector T cell transcriptional program
as t-bet and B lymphocyte-induced maturation protein-1 (Blimp-
1) can suppress CCR7 expression. Further, in the lymph nodes,
ﬁbroblastic reticular cells in T cell zones produce CCL19 and IL-7
(Link et al., 2007), thereby linking localization to T cell zones by
CCR7 to IL-7 signals supporting survival of effector cells. It will
be of great interest to determine whether it is simply the localiza-
tion driven by chemokines that is critical for effector CD8+ T cell
differentiation, or whether signaling by these chemokine recep-
tors also contributes to effector cell heterogeneity and memory
development.
TRANSCRIPTIONAL PROGRAMING OF KLRG1hiCD127lo
EFFECTOR T CELLS
In addition to t-bet, other transcription factors have been shown
to contribute to the formation of KLRG1hiCD127lo cells includ-
ing the inhibitor of differentiation 2 (Id2) and Blimp-1 (Kallies
et al., 2009; Yang et al., 2011). Id family proteins act as transcrip-
tional repressors and often combat e-box proteins (Murre, 2005).
Of the four members of Id family, both Id2 and Id3 are recip-
rocally expressed in effector CD8+ T cell subsets. Id2 is more
expressed in KLRG1hiCD127lo cells, while Id3 is more expressed
in KLRG1loCD127hi cells (Yang et al., 2011). Id2-deﬁcient mice
generated a substantially reduced effector CD8+ T cell response to
L. monocytogenes (Cannarile et al., 2006). This was further charac-
terized in a follow-up study, where Id2 was found to be required
for formation of KLRG1hiCD127lo cells; and Id3 was required for
formation of KLRG1loCD127hi effector CD8+ T cells (Yang et al.,
2011). Further studies showed that E proteins, E2A and HEB were
required for generation of memory precursor KLRG1loCD127hi
effector CD8+ T cells (D’Cruz et al., 2012). The limitation of
E2A/HEB activity by Id proteins appears to set the balance between
these two important effector T cell subsets.
Blimp1 is a transcription repressor in the PRDI-BF1 and RIZ
homology domain containing (PRDM) family and also appears
to contribute to formation of KLRG1hiCD127lo cells (Kallies
et al., 2009; Rutishauser et al., 2009). Similar to Id proteins and
E-box proteins, Blimp1 and another transcription repressor in
the BTB/PZ family, Bcl-6 act as antagonists of each other (Tun-
yaplin et al., 2004; Cimmino et al., 2008). Blimp1 expression is
higher in KLRG1hiCD127lo cells and the absence of Blimp-1
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impairs development of these cells (Rutishauser et al., 2009). Mul-
tiple mechanisms may contribute to Blimp-1’s role in promoting
KLRG1hiCD127lo cells, including antagonization of Bcl-6 (Mar-
tins et al., 2006; Kallies et al., 2009), repression of IL-2 production
(Martins et al., 2008). A recent report suggests that Blimp-1 may
repress expression of Id3 in KLRG1hiCD127lo cells and that lack
of this repression (i.e., in Blimp-1-deﬁcient mice) allows for their
persistence into the memory compartment and for expression
of E2A-driven genes important for genomic stability (Ji et al.,
2011). Thus, the current data suggest a model in which inﬂam-
mation drives expression of t-bet and an AKT/mTOR/FOXO
signaling network that may contribute directly (by inducing
Id2/Id3) or potentially in parallel with a Bcl-6/Id2/Id3 repressive
network.
TRANSCRIPTIONAL PROGRAMING OF MEMORY PRECURSOR
EFFECTOR T CELLS
Memoryprecursor effector cells are theYin to the SLECYang and as
such are often intertwined, experimental interpretations notwith-
standing. Nonetheless, several factors have been reported to
control the development of this effector cell population, including
Bcl-6, TCF-1, and Stat3 (Figure 2). Deﬁciency in Tcf-1, an effec-
tor of the Wnt signaling pathway, impairs proliferative responses
against Listeria infection and generation of KLRG1loCD127hi
effector CD8+ T cells after Listeria (Zhou et al., 2010) and lym-
phocytic choriomeningitis virus (LCMV) infections (Jeannet et al.,
2010). Zhou et al. (2010) also showed that Tcf-1 is essential for
optimal eomes and IL-2Rβ expression and forced overexpression
of eomes partially prevented the decline of effector cells, although
it did not appear to affect their surface marker phenotype. How-
ever, a role for β-catenin/wnt signaling on memory generation is
controversial as two recent studies found that loss of β-catenin did
not impair generation of effector responses (Driessens et al., 2010;
Prlic and Bevan, 2011). In these studies, T cell-speciﬁc loss of β-
catenin did not impair effector or secondary responses (as assessed
by the frequency of tetramer+ T cells up to day 30 after infec-
tion); however, the expression of KLRG1/CD127 markers were
not assessed in this study (Prlic and Bevan, 2011). Although it
is possible that a β-catenin-independent function of Tcf-1 could
contribute to formation of KLRG1loCD127hi cells, at least one
study suggests that the effects of Tcf-1 on memory T cell develop-
ment require its ability to interact with β-catenin (Jeannet et al.,
2010). Thus, more work is required to determine the role of the
wnt/β-catenin/Tcf-1 pathway on KLRG1loCD127hi cell formation
and memory development.
Another recent study implicated STAT3, downstream of IL-
10 and IL-21 signaling as a critical regulator of development of
memory precursor cells (Cui et al., 2011). Interestingly, this study
showed that T cell-speciﬁc loss of STAT3 or neutralization of IL-
10 in an IL-21-deﬁcient background lead to decreased percentage
and number of KLRG1loCD127hi cells but an increased number
of KLRG1hiCD127lo cells (Cui et al., 2011). Thus, while the overall
numbers of effector cells did not change, their phenotype did, an
important distinction and potential separation of the effects of dif-
ferentiation from effects on survival at a time when responses are
crashing. In this study, Stat3-deﬁcient effector T cells had normal
expressionof eomes, Blimp-1, andBcl-6 at the peakof the response
their levels decreased over time (Cui et al., 2011). However, it was
not apparent if this was a selective decrease in KLRG1loCD127hi
cells or the decrease was reﬂective of a shift in the effector subpop-
ulations (Cui et al., 2011). SOCS-3, a known STAT-3 target gene
was increased in wild type (WT) KLRG1loCD127hi cells at the
peak of the response, and these levels were decreased in STAT-3-
deﬁcient cells, but again, subset-speciﬁc expression was not clear.
Nonetheless, SOCS-3 overexpression in effector T cells reduced
their ability to activate STAT4, whilst SOCS-3 knockdown pro-
moted emergence of KLRG1hiCD127lo cells. However, it remains
unclear as to how these target genes may be selectively activated
in KLRG1loCD127hi cells because stimulation of effector CD8+
T cells with IL-10 and IL-21 lead to homogenous STAT3 activa-
tion (Cui et al., 2011). Together, the data suggest an intriguing
model whereby KLRG1loCD127hi cells are shielded from the dif-
ferentiating effects of inﬂammation by STAT3-driven induction of
SOCS-3.
PARALLELS BETWEEN EFFECTOR AND MEMORY SUBSETS
First described in humans, TCM express lymph node homing
receptors CD62L and CCR7 and are mostly found in the lymph
nodes and spleen as opposed to the TEM that lack CD62L and
CCR7 expression and instead express a variety of chemokine
receptors and tissue-speciﬁc homing receptors (Sallusto et al.,
1999; Masopust et al., 2001). These two subsets also differ in
their functional properties. TCM cells are capable of IL-2 produc-
tion, self-renewal and they are multi-potent cells that can rapidly
proliferate upon activation and generate effector cells (Wherry
et al., 2003). Numbers of TCM cells gradually increase over time
and outnumber TEM cells. While some studies suggest that the
TEM subset converts to TCM over time (Wherry et al., 2003), oth-
ers suggest that these lineages branch out early during memory
differentiation and they are not convertible (Marzo et al., 2005).
Adoptively transferred TEM cells were able to convert to CD62Lhi,
CCR7hi CD27hi cells that could produce IL-2 (Wherry et al., 2003).
However, responses of non-physiologically high numbers of P14
TCR transgenic T cells were shown to be different qualitatively
compared to endogenous effector cells (Marzo et al., 2005). Nev-
ertheless, both endogenous TEM cells and transfers of low number
of P14 cells were shown to convert to TCM subset upon trans-
fer (Sarkar et al., 2007). Although the conversion contributes to
the increase in TCM numbers, CD62Lhi effector T cells can be
detected early after the infection and they are enriched within
the KLRG1loCD127hi subset in the lymph nodes (Obar et al.,
2011). On the other hand, KLRG1hiCD127lo cells are low for
the expression of CD62L (Sarkar et al., 2008). Thus, in addi-
tion to conversion, higher proliferation and better survival of
TCM cells also contributes to the outgrowth of TCM cells later,
after the infection has cleared. Reacquisition of TCM phenotype
can be much slower after prime-boost immunizations (Jabbari
and Harty, 2006; Masopust et al., 2006). Also, a greater fraction
of secondary memory cells are KLRG1hiCD127hiCXCR3loCD27lo
phenotype (Masopust et al., 2006; Joshi et al., 2011). Although
the recall responses of the adoptively transferred secondary mem-
ory cells were found to be even more potent than the responses
of primary memory cells (Jabbari and Harty, 2006; Masopust
et al., 2006), third generation memory cells had lower recall
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responses upon adoptive transfers as a result of further differenti-
ation into KLRG1hi phenotype (Masopust et al., 2006). However,
if the prime-boost immunizations are done in the same host;
increased numbers of pre-existing memory cells prevent further
differentiation into KLRG1hiCXCR3loCD62LloCD27lo phenotype
(Joshi et al., 2011). Thus, the numbers of memory cells gen-
erated and the context of secondary priming conditions may
affect the phenotype of secondary memory cells and these
differences could play a role in the efﬁcacy of prime-boost
immunizations.
There are different models to explain the differentiation of
memory cells from effector cells:
The early fate determination model predicts that memory cell
heterogeneity, CD62Lhi – CD62Llo or CD127hi – CD127lo are
ﬁxed (pre-determined) at early times after infection. Indeed, effec-
tor cells with CD62L expression (Obar and Lefrancois, 2010) or
CD127 expression (Kaech et al., 2003) can be detected before the
peak of immune response. Similarly, Chang et al. (2007) visual-
ized the TCR transgenic cells after priming and just before the
ﬁrst division and found that certain cell surface molecules or TCR
signaling components segregated asymmetrically during division.
They showed that certain receptors segregated to the putative distal
pole relative to the microtubule organizing center (MTOC) which
is formed close to the immunological synapse. This resulted in
asymmetric cell division and the daughter cell containing the dis-
tal pole as to the synapse had more characteristics of memory T
cells such as CD62L. This study, although incomplete, provided
a mechanism as to how heterogeneity can be generated from a
single CD8+ T cell during the ﬁrst division (Chang et al., 2007).
However, CD62Llo effector cells can also convert to CD62Lhi cells
(Wherry et al., 2003; Sarkar et al., 2007) which suggest that there
is some ﬂexibility during memory differentiation.
The decreasing potential model suggests that every effector
cell has the potential to develop into a memory cell, but expo-
sure to inﬂammation and antigen for longer periods of time
can further differentiate effector cells into terminal effector cells
(KLRG1hiCD127lo) and decrease their potential to become mem-
ory cells (Ahmed and Gray, 1996; Badovinac et al., 2005; D’Souza
and Hedrick, 2006).
A modiﬁed model proposed by Kaech and Wherry (2007), fate
commitment with progressive differentiation suggests that there
are memory precursors within the KLRG1loCD127hi generated
early in the immune response, but these cells are not fully mature
memory cells and they require further differentiation. Although
these cells have the potential for memory differentiation, they
can develop into terminal effector cells (KLRG1hiCD127lo) if they
encounter inﬂammatory signals. Importantly, this model appears
to be consistent for the host response to several diverse infec-
tions (D’Souza and Hedrick, 2006; Badovinac and Harty, 2007;
Joshi et al., 2007). As mentioned previously, IL-10 and IL-21 act to
“shield” KLRG1loCD127hi cells from the effects of inﬂammation,
by increasing expression of SOCS3, which limits STAT-driven sig-
nals from inﬂammatory receptors (Cui et al., 2011). Thus, while
differential expression of KLRG1 and CD127 can crudely mark
cells with more or less memory potential, they likely require addi-
tional maturation signals and shielding from pro-inﬂammatory
cytokines as they develop into full-ﬂedged memory T cells.
ENDOGENOUS MEMORY CELLS – IRRELEVANT BYSTANDER
OR ACTIVE PARTICIPANT?
In addition to infection-induced memory cells, it is well known
that mice harbor populations of pre-existing memory T cells that
bear markers of memory (CD44, Ly6c, etc.). Notably, these cells
arise in mice that have not been purposefully challenged with
infection. Admittedly, some of these cells might be speciﬁc for
infections existing in some mouse colonies, for environmental
antigens, or for gut ﬂora. However, endogenous memory cells
exist in gnotobiotic mice and recent data suggest that a fair num-
ber of these cells arise during thymic development (Dobber et al.,
1992; Weinreich et al., 2010). A complex cellular and cytokine net-
work, involving NKT cells and IL-4 appears to contribute to the
development of pre-existing memory T cells, at least in Balb/c
mice (Weinreich et al., 2010). Interestingly, in the process of quan-
tifying the pre-existing naïve T cell compartment in unchallenged
animals using peptide–MHC tetramers, Kedl’s group found a sig-
niﬁcant frequency of T cells isolated from unchallenged mice
bore memory markers (Haluszczak et al., 2009). They showed
that, after puriﬁcation these endogenous memory cells responded
more robustly to stimulation, raising the intriguing possibility that
this heterogeneity in the naïve compartment might contribute to
effector T cell heterogeneity. On the other hand, in other experi-
ments, transfer of a single TCR Tg T cell shows that effector and
memory populations can arise from a single cell, a demonstra-
tion that differentiation from a common precursor is sufﬁcient
for effector and memory development. Whether or not there is a
signiﬁcant contribution of endogenous memory T cells to effec-
tor heterogeneity or whether these pre-existing cells contribute to
epitope dominance at the population level (or both) remains to be
determined.
APOPTOSIS AND THE DEVELOPMENT OF T CELL MEMORY
The molecular mechanisms responsible for apoptotic cell death
have been investigated intensely over the last few decades. Mam-
malian cells have two major pathways to execute apoptosis: the
extrinsic pathway (activated by death receptors of the TNF-R
superfamily); and the intrinsic pathway (mostly controlled by
members of the Bcl-2 gene family; Strasser, 2005). A considerable
amount of experimental effort has been put into understanding T
cell apoptosis. Initially, based on the discovery that defects in Fas
signaling led to the accumulation of T cells in autoimmune lym-
phoproliferative syndrome (ALPS) patients and lpr/gld mice, and
the requirement for Fas in an in vitromodel of activatedTcell death
it was assumed that Fas signaling was required for the contraction
of T cell responses (Watanabe-Fukunaga et al., 1992; Takahashi
et al., 1994; Brunner et al., 1995; Dhein et al., 1995; Fisher et al.,
1995; Rieux-Laucat et al., 1995). However, while in vitro experi-
ments readily showed a role for Fas/FasL signaling in activated T
cell death, several experiments showed that contraction of T cell
responses occurred readily in vivo in the absence of Fas signal-
ing (Desbarats et al., 1998; Hildeman et al., 2002; Pellegrini et al.,
2003). Thus, although disruptions of either pathway can affect T
cell homeostasis, recent research has suggested a critical role for
Bcl-2 family members and the intrinsic pathway in controlling
contraction of T cell responses (Hildeman et al., 2002; Pellegrini
et al., 2003; Wojciechowski et al., 2006).
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The Bcl-2 family can be classiﬁed into three subfamilies that
have either pro- or anti-apoptotic function. Group 1 consists of
anti-apoptotic Bcl-2-like molecules that contain most or all of the
four Bcl-2 homology (BH) domains. Group 2 consists of Bax-like
molecules that are pro-apoptotic and contain BH domains 1–3.
Group 3 consists of BH3-only molecules that are pro-apoptotic
and whose only homology to Bcl-2 lies in a short 9–10 amino
acid stretch termed the BH3 domain. Group 3 has the most mem-
bers, which appear to be expressed in a relatively tissue-speciﬁc
fashion (Youle and Strasser, 2008). BH3-only molecules appear
to transmit apoptotic signals to group two Bax-like molecules. In
the absence of the two predominant Bax-like molecules, Bax and
Bak, BH3-only proteins fail to induce apoptosis (Zong et al., 2001).
The mechanism(s) by which BH3-only molecules transmit signals
to Bax-like molecules remains the subject of some controversy.
One model proposes direct interactions between certain BH3-
only molecules and Bax-like molecules (Letai et al., 2002; Kuwana
et al., 2005; Kim et al., 2006), while another proposes that BH3-
only molecules sequester anti-apoptotic molecules from Bax-like
molecules and there is no direct interaction between BH3-only
and Bax-like molecules (Willis et al., 2007). Despite the contro-
versy both of these models highlight the importance of physical
interactions between Bcl-2 family members in cell death/survival
decisions. Thus, a major control point for cell death lies in the reg-
ulation of the balance between the levels of pro- and anti-apoptotic
molecules.
The ﬁrst experiment implicating Bcl-2 family members in
activated T cell death showed that overexpression of Bcl-2 was
sufﬁcient to prevent T cell deletion in response to staphylococ-
cal enterotoxin B (SEB; Strasser et al., 1991). We repeated this
experiment and found that, in contrast to loss of Fas and TNF-R
signaling, Bcl-2 overexpression gave a substantial protection from
SEB-induced deletion (Hildeman et al., 2002). Likewise, loss of
Bim provided a similar protection from deletion (Hildeman et al.,
2002). Although previous reports showed that transgenic Bcl-2
overexpression failed to prevent contraction of viral-speciﬁc T cell
responses, the level of the transgene across the response was never
examined (Petschner et al., 1998). Notably, by mechanisms that
remain unclear, the expression of endogenous Bcl-2 in the human
Bcl-2 transgenic mice that were used is substantially decreased, if
not all together absent (Jorgensen et al., 2007). Further, follow-
ing T cell activation, the levels of the Bcl-2 transgene also decline,
making it less potent. Subsequently, our and other groups have
observed that the loss of the Bcl-2 antagonist, Bim, prevents con-
traction of antigen-speciﬁc CD4+ and CD8+ T cell responses to
viral, bacterial, and parasitic infection (Pellegrini et al., 2003; Woj-
ciechowski et al., 2006; Prlic andBevan,2008; Reckling et al., 2008).
A major question is how T cells normally avoid Bim-driven death
on their way to becoming memory T cells.
REGULATION OF Bcl-2 BY γc CYTOKINES
Recent work from our and others groups have begun to address
that question. In T cells, major controllers of Bcl-2 expression
are the common gamma chain cytokines (Nakajima et al., 1997;
Schluns et al., 2000; Berard et al., 2003;Wojciechowski et al., 2007).
It has been known for some time that addition of IL-2, IL-4, IL-7,
and IL-15 to activated or resting T cells promotes the expression
of Bcl-2 (Vella et al., 1997, 1998) and Bcl-2 is largely required for in
vitro T cell survival in response to these cytokines (Wojciechowski
et al., 2007). The decreased expression of CD127 on the surface
of KLRG1hiCD127lo CD8+ T cells renders them less sensitive to
IL-7 and largely dependent upon IL-15 (Joshi et al., 2007; Rubin-
stein et al., 2008; Tripathi et al., 2010). CD127hi effector cells, on
the other hand, require IL-7 and IL-15 for their optimal survival,
although neutralization of IL-7 in an IL-15-deﬁcient background
only led to the loss of roughly half of this population (Tripathi
et al., 2010). Thus, other γc cytokines probably also play a role in
effector T cell survival because the loss of STAT5 signaling during
the response led to a dramatic loss of both effector CD8+ T cell
subsets (Tripathi et al., 2010). Mechanistically, STAT5 is critical for
the ability of IL-7 and IL-15 to promote Bcl-2 expression (Tripathi
et al., 2010). Thus, a common g cytokine/STAT5/Bcl-2 network is
critical for maintaining effector CD8+ T cell responses (Figure 2).
While cytokine signaling through STAT5 promotes expression
of Bcl-2 it has been reported that TGF-β signaling can antag-
onize Bcl-2 expression in KLRG1hiCD127lo cells (Sanjabi et al.,
2009). Adoptively transferredT cells expressing adnTGF-βR trans-
gene had substantially increased expansion of effector cells, which
was accompanied by increased expression of Bcl-2 (Sanjabi et al.,
2009). Further, there appeared to be an intersection with IL-15 in
this model, as transfer of dnTGF-βR Tg T cells into IL-15 deﬁ-
cient mice led to a partial restoration of Bcl-2 levels compared to
WT controls (Sanjabi et al., 2009). However, the increases in Bcl-2
were transient in dnTGF-βR Tg T cells and although there were
increased T cells at the peak of the response, the contraction of the
response was equal if not greater than the control, non-Tg animals
(Sanjabi et al., 2009). Also, following T cell activation, levels of
endogenous TGF-βR decline dramatically making it unclear if this
pathway is operative during the normal response or whether it is
magniﬁed by transgenic dnTGF-βR overexpression.
Bim/BcL-2 BALANCE IN EFFECTOR CD8+ T CELL SUBSETS
Initial work describing KLRG1loCD127hi and KLRG1hiCD127lo
cells, showed that Bcl-2 expressionwas higher inKLRG1loCD127hi
cells and thiswas attributed to their prolonged survival (Joshi et al.,
2007; Sarkar et al., 2008), however this was not formally tested.
Using a combination and genetic and pharmacologic approaches,
we tested the role of Bcl-2 in effector T cell survival, and its role
in combating Bim within the effector subsets. Interestingly, we
found that while Bcl-2 levels were higher in KLRG1loCD127hi
cells than KLRG1hiCD127lo cells, that Bim levels were also higher
(Kurtulus et al., 2011). Genetic loss or inhibition of Bcl-2 led to a
massive, Bim-dependent loss of KLRG1loCD127hi cells, and a less
profound, but still signiﬁcant loss of KLRG1hiCD127lo cells (Kur-
tulus et al., 2011). Notably, the cells that survived in the absence
of Bcl-2 had signiﬁcantly decreased levels of Bim (Kurtulus et al.,
2011). This phenomenon may also explain the “Bcl-2 indepen-
dence” of memory T cell survival reported in mice with a mutant
IL-7Rα transgene that is incapable of activating STAT5 and main-
taining signiﬁcant levels of Bcl-2 (Osborne et al., 2007). Thus, it is
likely that Bcl-2 is an obligate defender of Bim to maintain survival
of the memory precursor population, although the additional loss
of Bim did not completely restore precursor cell numbers, sug-
gesting that, in addition to restraining Bim, Bcl-2 may antagonize
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other pro-apoptotic molecules. Nonetheless, these data showed
that Bcl-2 levels determined the levels of Bim that effector T cells
can tolerate and survive (Figure 2).
While decreased expression of Bcl-2 certainly contributes to
the demise of effector CD8+ T cells, changes in Bim expression
are difﬁcult to detect because once past a certain Bcl-2 level, cells
having higher expression of Bim would be lost by apoptosis. We
circumvented this issue by using mice that were deﬁcient in Bak,
but had a T cell-speciﬁc loss of Bax, making them insensitive to
death driven byBH3-only Bcl-2 familymembers (Zong et al., 2001;
Kurtulus et al., 2011). Loss of Bax and Bak led to accrual of T cells
with signiﬁcantly increased levels of Bim, suggesting that there is
indeed a rather signiﬁcant transcriptional induction of Bimduring
the response (Kurtulus et al., 2011). Importantly, the levels of Bcl-2
were also decreased signiﬁcantly in these “undead” cells effectively
uncoupling concordant Bim and Bcl-2 expression. Because of the
inherent toxicities associated with altered expression of Bim, it has
been difﬁcult to determine the factors that control Bim expression
in T cells. However, recent work has suggested that FOXO3a and
Id2 may be regulators of Bim within effector T cells, as loss of
FOXO3a led to decreased Bim protein (Sullivan et al., 2012), while
loss of Id2 led to increased Bim mRNA (Cannarile et al., 2006). It
is possible that there are intersections between FOXO3a and Id2
proteins, as deﬁciencies in either molecule led to major effects on
expansion but rather minor effects on contraction of the response
(Figure 2). Thus, more work will be necessary to clearly examine
the complex transcriptional network underlying effector T cell
contraction.
DEVELOPMENT OF CD4 MEMORY – CONSIDERABLY
DIFFERENT FROM DEVELOPMENT OF CD8 MEMORY
Although much more work has been done to deﬁne effector T cell
subsets and control of CD8+ T cell memory, clues are emerg-
ing to deﬁne effector CD4 responses and the development of
memory CD4+ T cells. Interestingly, it appears that the mark-
ers expressed on effector CD8+ T cells and those expressed on
effector CD4+ T cells are quite distinct. For example, expression
of CD127 on effector CD4+ T cells is more dynamic; CD127lo
effector CD4+ T cells readily re-express CD127. Several recent
studies have examined heterogeneity within effector CD4+ T cells.
One study found that subsets of effector CD4+ T cells could
be deﬁned based expression of P-selectin ligand-1 (PSGL-1) and
Ly6C into three distinct, PSGL-1lowLy6Clow, PSGL-1hiLy6Clow,
and PSGL-1hiLy6Chi (Marshall et al., 2011). Over time after infec-
tion, there was a slight enrichment for PSGL-1hiLy6Clow cells, but
this enrichment was not nearly as dramatic as the enrichment
for KLRG1loCD127hi cells within the effector CD8 compartment.
However, similar to the KLRG1hiCD127lo CD8+ T cells PSGL-
1hiLy6Chi CD4+ population required t-bet expression (Marshall
et al., 2011). Thus, while effector PSGL-1hiLy6Clow cells appeared
to be more capable of expanding in response to a secondary chal-
lenge, and that they share a similar transcriptional proﬁle with
memory CD4+ T cells (Marshall et al., 2011), suggests that this
subset most likely contains memory precursors.
On the other hand, another study deﬁned effector CD4+ sub-
sets via expression of CXCR5 and PD-1 (Pepper et al., 2011).
Effector CD4+ T cells were again divided into three major subsets,
cells expressing CCR7 along with intermediate levels of CXCR5
and lacking PD-1 (termed Tcm), those expressing t-bet, but not
CCR7, CXCR5 nor PD-1 (Th1), and those expressing CXCR5 and
PD-1 (Tfh). While Tfh cells waned dramatically over time, Th1
cells contracted more vigorously and Tcm cells contracted less
vigorously (Pepper et al., 2011). In secondary responses, Tcm cells
gave rise to all three subsets, while Th1 cells gave rise to only Th1
cells, suggesting that the Th1 cells, when they exist as memory cells
are less able to give rise to the other subsets, while subset differ-
entiation ability is maintained in the Tcm population. This study
also showed that the Th1 cells largely required CD25 expression,
while Bcl-6 was critical for Tcm cells as was inducible costimulator
(ICOS) stimulation from B cells (Pepper et al., 2011). Importantly,
while Tcm and Tfh both required Bcl-6, it is notable that they
are discrete populations due to their differential localization after
adoptive transfer and the fact that Tcm cells are inefﬁcient at pro-
ducing Tfh cells in secondary responses (Pepper et al., 2011). The
overlap and relationship between the effector CD4+ T cell subsets
identiﬁed by these two studies remains unclear and awaits further
investigation.
The expansion and contractionof theCD4+ Tcell response also
shares both similarities and differences contraction of the CD8+
T cell response. It has been known for some time that expan-
sion of the CD4 response is less robust than the CD8 response
(Homann et al., 2001). Further, the decline of the antigen-speciﬁc
effector CD4+ T cells after the peak of the response is less steep
(90–95% of effector CD8s are lost; compared to 75–80% of effec-
tor CD4s) within the 2–3 weeks after the peak of the response
(Figure 1). After that early contraction, memory CD8+ T cells are
maintained at a constant level while CD4+ T cells decline slowly
over time (Homann et al., 2001; Pepper et al., 2011; Figure 1).
However, the pro-apoptotic molecule Bim is critical to the demise
of both populations; the absence of Bim spares roughly 80% of
the effector CD8+ T cells and >90% of the effector CD4+ T cells
(Wojciechowski et al., 2006). Interestingly, there are some basic
differences in how effector CD4+ versus CD8+ T cells combat
Bim in order to enter the memory compartment. We and others
recently showed that IL-7 and IL-15 contribute to survival of effec-
tor CD8+ T cells by promoting expression of Bcl-2 through STAT5
(Schluns et al., 2000, 2002; Rubinstein et al., 2008; Tripathi et al.,
2010). However, we found that neutralization of IL-7 in IL-15-
deﬁcient mice did not result in signiﬁcantly increased contraction
of the CD4+ T cell response (Tripathi et al., 2010). Further, we
found that, in contrast to CD8+ T cells, effector CD4+ T cells
were much more able to tolerate the loss of STAT5 and persisted
for some time as STAT5low effector T cells (Tripathi et al., 2010).
Similarly, neutralization of Bcl-2 does not exacerbate contraction
of the CD4+ T cell response (Tripathi et al., 2007), suggesting
that, in effector CD4+ T cells, something other than Bcl-2 com-
bats Bim. Thus, while there are some similarities with effector to
memory transition between CD4+ and CD8+ T cells more work is
necessary to untangle the mechanisms that control this transition.
FUTURE DIRECTIONS
Recent progress has greatly improved our understanding of how
memory T cells emerge from the effector pool. Death and
differentiation work together to shape the effector T cell response.
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Most effector T cells that are generated die shortly after the peak
of the response. This death process is largely mediated by the
pro-apoptotic Bcl-2 family member, Bim. Bim function is neg-
atively controlled by the levels of Bcl-2, which are regulated by
the availability of common gamma chain cytokines. Death and
differentiation could be manipulated to enhance the death of
autoreactive T cells. On the other hand, manipulation of death
and differentiation processes could be exploited to improve vac-
cine responses. For example, recent work from us and other
have suggested that IL-7 may be an excellent vaccine adjuvant,
promoting strong effector T cell responses to help B cells make
antibody as well as promoting strong effector CD4+ and CD8+
T cell responses (Tripathi et al., 2007; Nanjappa et al., 2008; Nam
et al., 2010; Pellegrini et al., 2011). However, the effects of IL-7
are somewhat short-lived as they wane with the withdrawal of
the cytokine. Thus, factors that restrict cellular differentiation
(i.e., IL-10, IL-21) may be combined with IL-7 therapy to boost
long-lived centralmemory T cells. Thismay be particularly advan-
tageous for vaccines that require boosting to achieve immunity,
such as the hepatitis B vaccine. Conversely, other vaccines may
beneﬁt from effector memory T cells, which are maintained in the
tissues and provide substantial protection from tissue borne infec-
tions (Bachmann et al., 2005). For example, adenoviral vaccines
appear to promote strong effector T cells that appear to persist as
effector memory cells (Reyes-Sandoval et al., 2011). Thus, more
research is necessary to deﬁne successful immunization strategies
that maximize protective immunity. Exploitation of combinato-
rial strategies aimed at controlling the type of inﬂammation with
enhancing effector T cell survival may provide approaches that
could be tailored to the particular infectious disease.
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